STUDY TITLE: (ACRONYM) PANDA PIC - This activity is considered a Patient What are the indications for Prescribing Identification Centre study ANtiDepressAnts that will lead to a clinical benefit? NIHR PORTFOLIO REF: 16264 NHS ETHICS REF: 135094 Professor Glyn FUNDER: NIHR SPONSOR: University College London (UCL) CHIEF INVESTIGATOR: Lewis MAIN STUDY OBJECTIVE: The primary objective is to investigate the severity and duration of the depressive symptoms that are associated with a clinically important response (compared to placebo) to sertraline in people with depression. The secondary objective is to investigate quality of life, the economic cost and whether performances on emotional processing tasks are associated with response to treatment with sertraline RECRUITMENT PERIOD: August 2017 POPULATION: 50 from West Midlands LOCAL CO-ORDINATOR/FACILITATOR: TEL: 0121 4146643 EMAIL: Anuradha.Krishna @nihr.ac.uk ADDRESS: Clinical Research Network: Primary Care, Primary Care Clinical Sciences, Learning Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT FAX REPLY: 0121 414 6571 PANDA YES PLEASE I would be interested in finding out more about this study. NO THANK YOU, I am not interested at this time. PRACTICE CODE: It would be helpful to the study team if you could indicate below why your PRACTICE NAME: practice would not wish to be involved at this time: CCG: Practice to complete PRACTICE ADDRESS: Too busy Funding Study not suitable PRACTICE CONTACT: ROLE: Practice not interested in research Other Tel: Email:
STUDY TITLE: What are the indications for Prescribing ANtiDepressAnts that will lead to a clinical benefit? (ACRONYM) PANDA PIC - This activity is considered a Patient Identification Centre study NIHR PORTFOLIO REF: 16264 NHS ETHICS REF: 135094 CHIEF INVESTIGATOR: Professor Glyn Lewis FUNDER: NIHR SPONSOR: University College London (UCL) MAIN STUDY OBJECTIVE: The primary objective is to investigate the severity and duration of the depressive symptoms that are associated with a clinically important response (compared to placebo) to sertraline in people with depression. The secondary objective is to investigate quality of life, the economic cost and whether performances on emotional processing tasks are associated with response to treatment with sertraline RECRUITMENT PERIOD: August 2017 POPULATION: 50 from West Midlands LOCAL CO-ORDINATOR/FACILITATOR: TEL: 0121 4146643 EMAIL: Anuradha.Krishna @nihr.ac.uk ADDRESS: Clinical Research Network: Primary Care, Primary Care Clinical Sciences, Learning Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT FAX REPLY: 0121 414 6571 PANDA YES PLEASE I would be interested in finding out more about this study. NO THANK YOU, I am not interested at this time. It would be helpful to the study team if you could indicate below why your practice would not wish to be involved at this time: Too busy Funding Study not suitable Practice not interested in research Other PRACTICE CODE: PRACTICE NAME: CCG: Practice to complete PRACTICE ADDRESS: PRACTICE CONTACT: ROLE: Tel: Email:
PANDA-EOI-Form.docx